Tci Wealth Advisors, Inc. Intellia Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$33.3 - $44.82 $6,360 - $8,560	191 New	191 $7,000
Q3 2022 Nov 08, 2022	SELL	$53.92 - $71.7 $431 - $573	-8 Reduced 5.71%	132 $7,000
Q2 2022 Jul 19, 2022	BUY	$38.49 - $76.21 $1,770 - $3,505	46 Added 48.94%	140 $7,000
Q1 2022 Apr 29, 2022	SELL	$58.27 - $118.99 $2,214 - $4,521	-38 Reduced 28.79%	94 $7,000
Q3 2021 Oct 29, 2021	SELL	$132.37 - $176.78 $264 - $353	-2 Reduced 1.49%	132 $18,000
Q2 2021 Aug 02, 2021	BUY	$60.88 - $161.91 $3,165 - $8,419	52 Added 63.41%	134 $22,000
Q1 2021 Apr 29, 2021	BUY	$46.59 - $83.68 $2,888 - $5,188	62 Added 310.0%	82 $7,000
Q3 2020 Oct 20, 2020	SELL	$17.47 - $24.93 $174 - $249	-10 Reduced 33.33%	20 $0
Q1 2020 Apr 14, 2020	BUY	$9.44 - $15.58 $283 - $467	30 New	30 $0

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $929M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.